Lapides Asset Management, LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 26 filers reported holding PSYCHEMEDICS CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lapides Asset Management, LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2021$137,000
+18.1%
16,300
-2.4%
0.06%
+23.9%
Q2 2021$116,000
-12.1%
16,700
-21.6%
0.05%
-16.4%
Q1 2021$132,000
+112.9%
21,300
+74.6%
0.06%
+103.7%
Q4 2020$62,000
-39.2%
12,200
-47.4%
0.03%
-51.8%
Q3 2020$102,000
-1.0%
23,200
+24.7%
0.06%
-6.7%
Q2 2020$103,000
-52.1%
18,600
+73.8%
0.06%
+50.0%
Q1 2017$215,000
+87.0%
10,700
-5.3%
0.04%
+100.0%
Q4 2015$115,000
+3.6%
11,300
+2.7%
0.02%
+5.3%
Q3 2015$111,00011,0000.02%
Other shareholders
PSYCHEMEDICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 362,166$5,371,0004.20%
KELLEHER FINANCIAL ADVISORS 135,838$2,014,0001.15%
NAPLES GLOBAL ADVISORS, LLC 67,032$994,0000.48%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 193,500$2,870,0000.36%
North Star Investment Management Corp. 112,950$1,675,0000.31%
Uniplan Investment Counsel, Inc. 364,831$5,410,0000.25%
Moors & Cabot, Inc. 98,374$1,450,0000.24%
RBF Capital, LLC 78,495$1,164,0000.22%
CARL DOMINO INC 20,272$301,0000.20%
Granite Investment Partners, LLC 70,435$1,044,0000.10%
View complete list of PSYCHEMEDICS CORP shareholders